Skip to main content

Table 1 The clinicopathological characteristics of studied patients

From: The role of protein inhibitor of activated STAT3 and miRNA-18a expressions in breast cancer

Variables Patients
(n = 25)
(%)
Age (years)
 > 50 13 52
 ≤ 50 12 48
Focality
 Unifocal 23 92
 Multifocal 2 8
Tumor size
 < 2 cm 14 56
 ≥ 2 cm 11 44
Histopathological type
 IDC 20 80
 ILC 1 4
 DCIS 4 16
Pathological grade
 GI 4 16
 GII 15 60
 GIII 6 24
Lymphovascular invasion
 Negative 3 12
 Positive 22 88
LN metastasis
 No 12 48
 Yes 13 52
TNM stage
 IA 7 28
 IIA + IIB 13 52
 III 5 20
ER
 Positive 19 76
 Negative 6 24
PR
 Positive 19 76
 Negative 6 24
HER2
 Positive 20 80
 Negative 5 20
Molecular type
 Luminal A 5 20
 Luminal B 14 56
 HER2 enriched 6 24
  1. n number, LN lymph node, ER estrogen receptors, PR progesterone receptors, HER2 epidermal growth factor receptor 2, TNM tumor-node-metastasis classification system